Commentary: Erythropoietin as a treatment option for indirect optic neuropathy: A pilot study.
作者信息
Goyal Jawahar Lal, Holmes Naorem
机构信息
Department of Ophthalmology, Sharda University, Greater Noida, Uttar Pradesh, India.
Department of School of Medical Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, India.
出版信息
Indian J Ophthalmol. 2023 Jan;71(1):241. doi: 10.4103/ijo.IJO_2248_22.
Abstract
摘要
相似文献
1
Commentary: Erythropoietin as a treatment option for indirect optic neuropathy: A pilot study.评论：促红细胞生成素作为间接性视神经病变的一种治疗选择：一项初步研究。
Indian J Ophthalmol. 2023 Jan;71(1):241. doi: 10.4103/ijo.IJO_2248_22.
2
Erythropoietin in Treatment of Methanol Optic Neuropathy.促红细胞生成素治疗甲醇中毒性视神经病变。
J Neuroophthalmol. 2018 Jun;38(2):167-171. doi: 10.1097/WNO.0000000000000614.
3
Erythropoietin treatment for methanol optic neuropathy.红细胞生成素治疗甲醇中毒性视神经病变。
J Neuroophthalmol. 2012 Dec;32(4):325-8. doi: 10.1097/WNO.0b013e318262a7c2.
4
Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.促红细胞生成素在视神经病变中的应用：视神经保护和修复的当前和未来策略。
Int J Mol Sci. 2022 Jun 27;23(13):7143. doi: 10.3390/ijms23137143.
5
Evaluation of the effect of erythropoietin + corticosteroid versus corticosteroid alone in methanol-induced optic nerve neuropathy.评估促红细胞生成素联合皮质类固醇与单独使用皮质类固醇治疗甲醇所致视神经病变的效果。
Cutan Ocul Toxicol. 2018 Jun;37(2):186-190. doi: 10.1080/15569527.2017.1373121. Epub 2017 Sep 14.
6
Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases.促红细胞生成素在视网膜和视神经疾病中的治疗潜力
CNS Neurol Disord Drug Targets. 2015;14(9):1225-34. doi: 10.2174/1871527314666150821104800.
7
Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy.促红细胞生成素作为甲醇所致中毒性视神经病变的辅助治疗手段。
Am J Drug Alcohol Abuse. 2016 Nov;42(6):633-639. doi: 10.1080/00952990.2016.1198800. Epub 2016 Jul 27.
8
Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial.创伤性视神经病变治疗试验（TONTT）：开放标签、3期、多中心、半实验性试验。
Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):209-218. doi: 10.1007/s00417-017-3816-5. Epub 2017 Oct 6.
9
An Updated Review on the Most Common Agents Causing Toxic Optic Neuropathies.关于引起中毒性视神经病变的最常见因素的最新综述
Curr Pharm Des. 2017;23(4):586-595. doi: 10.2174/1381612823666170124113826.
10
Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.托珠单抗作为格雷夫斯眼眶病继发视神经病变的一线治疗选择。
Orbit. 2018 Dec;37(6):450-453. doi: 10.1080/01676830.2018.1435694. Epub 2018 Feb 8.
本文引用的文献
1
Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.促红细胞生成素在视神经病变中的应用：视神经保护和修复的当前和未来策略。
Int J Mol Sci. 2022 Jun 27;23(13):7143. doi: 10.3390/ijms23137143.
2
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study.促红细胞生成素治疗视神经炎患者的安全性和有效性（TONE）：一项随机、双盲、多中心、安慰剂对照研究。
Lancet Neurol. 2021 Dec;20(12):991-1000. doi: 10.1016/S1474-4422(21)00322-7.
3
The effect of systemic erythropoietin and oral prednisolone on recent-onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial.系统性促红细胞生成素与口服泼尼松龙对近期发病的非动脉炎性前部缺血性视神经病变的影响：一项随机临床试验。
Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2291-2297. doi: 10.1007/s00417-020-04781-x. Epub 2020 Jun 6.
4
Traumatic optic neuropathy-Clinical features and management issues.外伤性视神经病变——临床特征与处理问题
Taiwan J Ophthalmol. 2015 Mar 1;5(1):3-8. doi: 10.1016/j.tjo.2015.01.003.
5
A pilot study of the effect of intravenous erythropoetin on improvement of visual function in patients with recent indirect traumatic optic neuropathy.静脉注射促红细胞生成素对近期间接性外伤性视神经病变患者视觉功能改善作用的初步研究。
Graefes Arch Clin Exp Ophthalmol. 2014 Aug;252(8):1309-13. doi: 10.1007/s00417-014-2691-6. Epub 2014 Jul 2.
6
Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy.玻璃体内注射红细胞生成素治疗非动脉炎性前部缺血性视神经病变。
Br J Ophthalmol. 2011 Jul;95(7):992-5. doi: 10.1136/bjo.2010.191627. Epub 2010 Dec 3.
Zotero 插件